CLOV (Clover Health Investments) ROCE % : -9.72% (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Clover Health Investments's annualized ROCE % for the quarter that ended in Sep. 2024 was -9.72%.

Clover Health Investments ROCE % Historical Data

The historical data trend for Clover Health Investments's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments ROCE % Chart

Clover Health Investments Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-153.94

-167.60

-70.81

-62.14

Clover Health Investments Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-38.90	-87.49	-28.61	8.62	-9.72

Clover Health Investments ROCE % Calculation

Clover Health Investments's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-213.354	/	( ( (808.62 - 431.507)	+	(570.671 - 261.115) )	/ 2 )
	=	-213.354	/	( (377.113	+	309.556)	/ 2 )
	=	-213.354	/	343.3345
	=	-62.14 %

Clover Health Investments's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-35.14	/	( ( (674.21 - 324.511)	+	(653.013 - 279.635) )	/ 2 )
	=	-35.14	/	( ( 349.699	+	373.378 )	/ 2 )
	=	-35.14	/	361.5385
	=	-9.72 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Clover Health Investments (NAS:CLOV) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Clover Health Investments ROCE % Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Clover Health Investments Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » ROCE %

Comparable Companies

BHG PFHO MRAI OSCR ALHC UNH ELV CI CVS HUM CNC MOH SZSE:000503 BSP:ODPV3 BSP:QUAL3 ROCO:6665 MIL:HI TSXV:NXG

Traded in Other Exchanges

7QD:Germany

Address

3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067

Website

https://www.cloverhealth.com

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. Operating in two segments, Insurance and Non-Insurance, Clover Health offers PPO and HMO plans to Medicare Advantage members in multiple states through its Insurance segment. In the Non-Insurance segment, the company participates in the ACO REACH Model. The majority of revenue is generated from the insurance segment, reflecting the significance of its healthcare insurance offerings.

Executives

Vivek Garipalli	director, 10 percent owner, officer: Executive Chairperson	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Anna U Loengard	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Karen Soares	officer: General Counsel & Secretary	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy	director, officer: Chief Executive Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler	officer: Chief Financial Officer	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest	officer: CEO of Home Care	C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp	officer: CEO of Value-Based Care	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad	officer: Chief Technology Officer	3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin	officer: General Counsel	C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Carladenise Armbrister Edwards	director	C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton	director	C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso	officer: CEO of Medicare Advantage	C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya	10 percent owner, other: See Remarks	THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025